Gagnon Advisors’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.23M Hold
274,217
3.85% 11
2025
Q4
$6.63M Hold
274,217
4.21% 13
2025
Q3
$7M Hold
274,217
4.32% 10
2025
Q2
$5.91M Hold
274,217
3.97% 11
2025
Q1
$6.26M Hold
274,217
4.42% 10
2024
Q4
$7.12M Hold
274,217
4.56% 8
2024
Q3
$6.87M Hold
274,217
4.43% 8
2024
Q2
$5.88M Hold
274,217
4.47% 8
2024
Q1
$5.09M Hold
274,217
4.41% 10
2023
Q4
$4.46M Sell
274,217
-86,541
-24% -$1.1M 3.89% 15
2023
Q3
$4.98M Hold
360,758
4.17% 11
2023
Q2
$7.97M Hold
360,758
5.34% 7
2023
Q1
$7.85M Buy
360,758
+55,848
+18% +$1.26M 5.27% 6
2022
Q4
$5.55M Hold
304,910
3.75% 13
2022
Q3
$6.94M Hold
304,910
4.49% 9
2022
Q2
$4.21M Buy
304,910
+98,942
+48% +$1.45M 2.55% 18
2022
Q1
$4.68M Buy
205,968
+30,693
+18% +$808K 2.16% 19
2021
Q4
$6.53M Hold
175,275
2.59% 18
2021
Q3
$7.42M Sell
175,275
-19,475
-10% -$938K 2.94% 17
2021
Q2
$8.67M Hold
194,750
3.29% 13
2021
Q1
$7.01M Hold
194,750
2.89% 14
2020
Q4
$7.77M Hold
194,750
3.49% 11
2020
Q3
$5.64M Buy
194,750
+75,469
+63% +$1.63M 3.46% 14
2020
Q2
$1.95M Buy
+119,281
New +$1.64M 1.4% 22

Other funds holding BLFS

Gagnon Advisors's BLFS Position: Q1 2026 in Review

Gagnon Advisors held its BioLife Solutions (BLFS) position steady in Q1 2026 at 274,217 shares worth $5.23M. The position accounts for 3.85% of the portfolio, ranked #11.

Gagnon Advisors first reported a position in BLFS in Q2 2020 and has held it in 24 quarters since. The position peaked at $8.67M in Q2 2021. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Gagnon Advisors held 274,217 shares of BioLife Solutions worth $5.23M as of Q1 2026.
  • Gagnon Advisors left its BioLife Solutions share count unchanged in Q1 2026.
  • BioLife Solutions made up 3.85% of Gagnon Advisors's portfolio in Q1 2026, its #11 holding.
  • Gagnon Advisors first reported a position in BioLife Solutions in Q2 2020 and has held it in 24 quarters since.
  • Gagnon Advisors's BioLife Solutions position peaked at $8.67M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Gagnon Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.